Cited In for PMID: 17576927

Year	Number of Results
2007	1
2008	2
2009	6
2010	4
2011	5
2012	14
2013	11
2014	7
2015	8
2016	9
2017	15
2018	17
2019	17
2020	20
2021	11
2022	14
2023	15
2024	2

1

CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia.

Hosen N, Park CY, Tatsumi N, Oji Y, Sugiyama H, Gramatzki M, Krensky AM, Weissman IL. Hosen N, et al. Proc Natl Acad Sci U S A. 2007 Jun 26;104(26):11008-13. doi: 10.1073/pnas.0704271104. Epub 2007 Jun 18. Proc Natl Acad Sci U S A. 2007. PMID: 17576927 Free PMC article.

2

Targeting TIGIT for cancer immunotherapy: recent advances and future directions.

Zhang P, Liu X, Gu Z, Jiang Z, Zhao S, Song Y, Yu J. Zhang P, et al. Biomark Res. 2024 Jan 16;12(1):7. doi: 10.1186/s40364-023-00543-z. Biomark Res. 2024. PMID: 38229100 Free PMC article. Review.

3

Blast-Derived Small Extracellular Vesicles in the Plasma of Patients with Acute Myeloid Leukemia Predict Responses to Chemotherapy.

Boyiadzis M, Hong CS, Yerneni S, Im A, Diergaarde B, Whiteside TL. Boyiadzis M, et al. Biomedicines. 2023 Dec 7;11(12):3236. doi: 10.3390/biomedicines11123236. Biomedicines. 2023. PMID: 38137457 Free PMC article.

4

A guide to epigenetics in leukaemia stem cells.

Agrawal-Singh S, Bagri J, Sakakini N, Huntly BJP. Agrawal-Singh S, et al. Mol Oncol. 2023 Dec;17(12):2493-2506. doi: 10.1002/1878-0261.13544. Epub 2023 Nov 2. Mol Oncol. 2023. PMID: 37872885 Free PMC article. Review.

5

Therapeutic targeting of leukemia stem cells in acute myeloid leukemia.

Barbosa K, Deshpande AJ. Barbosa K, et al. Front Oncol. 2023 Aug 3;13:1204895. doi: 10.3389/fonc.2023.1204895. eCollection 2023. Front Oncol. 2023. PMID: 37601659 Free PMC article. Review.

6

Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance.

Ajmeera D, Ajumeera R. Ajmeera D, et al. Genes Dis. 2023 Jan 20;11(1):148-175. doi: 10.1016/j.gendis.2022.12.013. eCollection 2024 Jan. Genes Dis. 2023. PMID: 37588226 Free PMC article. Review.

7

The Therapeutic Potential of a Strategy to Prevent Acute Myeloid Leukemia Stem Cell Reprogramming in Older Patients.

Park MN. Park MN. Int J Mol Sci. 2023 Jul 27;24(15):12037. doi: 10.3390/ijms241512037. Int J Mol Sci. 2023. PMID: 37569414 Free PMC article. Review.

8

Biomarkers as targets for CAR-T/NK cell therapy in AML.

Shao R, Li Z, Xin H, Jiang S, Zhu Y, Liu J, Huang R, Xu K, Shi X. Shao R, et al. Biomark Res. 2023 Jun 17;11(1):65. doi: 10.1186/s40364-023-00501-9. Biomark Res. 2023. PMID: 37330575 Free PMC article. Review.

9

Triptoquinone A and B exercise a therapeutic effect in systemic lupus erythematosus by regulating NLRC3.

Xu Q, Zhang X, Ge S, Xu C, Lv Y, Shuai Z. Xu Q, et al. PeerJ. 2023 Jun 9;11:e15395. doi: 10.7717/peerj.15395. eCollection 2023. PeerJ. 2023. PMID: 37312878 Free PMC article.

10

Detection and targeting of splicing deregulation in pediatric acute myeloid leukemia stem cells.

van der Werf I, Mondala PK, Steel SK, Balaian L, Ladel L, Mason CN, Diep RH, Pham J, Cloos J, Kaspers GJL, Chan WC, Mark A, La Clair JJ, Wentworth P, Fisch KM, Crews LA, Whisenant TC, Burkart MD, Donohoe ME, Jamieson CHM. van der Werf I, et al. Cell Rep Med. 2023 Mar 21;4(3):100962. doi: 10.1016/j.xcrm.2023.100962. Epub 2023 Mar 7. Cell Rep Med. 2023. PMID: 36889320 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

159 results

Results by year